Current and Emerging Pharmacotherapeutic Options for Smoking Cessation
Tobacco smoking remains the single most preventable cause of morbidity and mortality in developed countries and poses a significant threat across developing countries where tobacco use prevalence is increasing. Nicotine dependence is a chronic disease often requiring multiple attempts to quit; repea...
Main Authors: | Kristin V. Carson, Malcolm P. Brinn, Thomas A. Robertson, Rachada To-A-Nan, Adrian J. Esterman, Matthew Peters, Brian J. Smith |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2013-01-01
|
Series: | Substance Abuse: Research and Treatment |
Online Access: | https://doi.org/10.4137/SART.S8108 |
Similar Items
-
Current and Emerging Pharmacotherapeutic Options for Smoking Cessation
by: Kristin V. Carson, et al.
Published: (2013-05-01) -
Two-year efficacy of varenicline tartrate and counselling for inpatient smoking cessation (STOP study): A randomized controlled clinical trial.
by: Kristin V Carson-Chahhoud, et al.
Published: (2020-01-01) -
Community pharmacy personnel interventions for smoking cessation
by: Carson-Chahhoud, K, et al.
Published: (2019) -
Pharmacotherapeutic Options for Ophthalmic Conjunctivitis
by: A. D. van Eyk
Published: (2018-06-01) -
Pharmacotherapeutic Options for Visceral Leishmaniasis—Current Scenario
by: Krishna Pandey MD, et al.
Published: (2009-01-01)